Goal #7:  Training and career support programs for translational scientists

Presentation: Data Management for Biomedical ResearchDate/Time: Friday, October 17, 2024, from 2:00 p.m. ETLocation: <a href="https://rocku.zoom.us/meeting/register/tJcoc-2srjMqGNSJbON92lgCQ702nRS3g7gZ#/registration" target="_blank" rel="noopener noreferrer">Zoom</a>Speaker: Claire Warner, Ph.D.&nbsp;Register <a href="https://rocku.zoom.us/meeting/register/tJcoc-2srjMqGNSJbON92lgCQ702nRS3g7gZ#/registration" target="_blank" rel="noopener noreferrer">here</a>.

Rockefeller University Center for Clinical and Translational Science

large_Rockefeller saliva test for COVID-19 outperforms commercial swab tests.png

medium_Rockefeller saliva test for COVID-19 outperforms commercial swab tests.png

small_Rockefeller saliva test for COVID-19 outperforms commercial swab tests.png

thumbnail_Rockefeller saliva test for COVID-19 outperforms commercial swab tests.png

Rockefeller saliva test for COVID-19 outperforms commercial swab tests.png

Rockefeller University

Rockefeller University CCTS R3 - Enhancing Scientific Rigor, Reproducibility, and Reporting Series

- Any -

Goal #3: Address health disparities 

Dr. David Tofovic, a rising star in cardiology, is paving new paths in the study of cardiovascular health, particularly in patients with sickle cell disease.&nbsp;An assistant professor in the division of cardiology and University of Chicago Illinois (UIC) Center for Clinical and Translational Science KL2 scholar, Dr. Tofovic leads innovative projects like the UIC Sickle Cell Disease Cardiovascular Database -S(CD)2– and the Multi-Ethnic Dilated Cardiomyopathy Registry. He shared insights into his research on atrial fibrillation in sickle cell patients and his efforts to address disparities in heart health among underrepresented groups.&nbsp;Sickle cell disease affects an estimated 25-35 million people globally, yet Dr. Tofovic believes that current research significantly underrepresents the full impact of the condition. He emphasizes that sickle cell is not just a blood disorder but a systemic disease impacting multiple organs, including the heart. With patients living longer due to medical advancements, Dr. Tofovic’s research focuses on understanding how sickle cell disease affects the cardiovascular system over time…&nbsp;Read the full article and listen to the podcast <a href="https://ccts.uic.edu/news-stories/podcast-tofovic/" target="_blank" rel="noopener noreferrer">here</a>.

University of Illinois at Chicago Center for Clinical and Translational Science

small_Podcast-Researcher-Spotlight_Tofovic.webp

thumbnail_Podcast-Researcher-Spotlight_Tofovic.webp

Podcast-Researcher-Spotlight_Tofovic.webp

University of Illinois at Chicago

David Tofovic, M.D., Heart Health and Sickle Cell Disease

X-logo-teal_80x66.png

ri_linkedin_fill_408497d4b5_96748f4451.png

Presentation: COVID ReinfectionsDate/Time: Friday, October 14, 2024, from 5:00 p.m. ETLocation: ZoomSpeakers: Richard Moffitt and Emily Hadley&nbsp;Description coming soon!&nbsp;Register <a href="https://n3c-info.zoom.us/webinar/register/WN_ip6MsjixRzy1wV9JX2ph8A" target="_blank" rel="noopener noreferrer">here</a>.View more information <a href="https://covid.cd2h.org/forum/" target="_blank" rel="noopener noreferrer">here</a>.

Not affiliated with any listed CTSA hubs

large_Another Published Preprint  from the National COVID Cohort Collaborative (N3C).png

medium_Another Published Preprint  from the National COVID Cohort Collaborative (N3C).png

small_Another Published Preprint  from the National COVID Cohort Collaborative (N3C).png

thumbnail_Another Published Preprint  from the National COVID Cohort Collaborative (N3C).png

Another Published Preprint  from the National COVID Cohort Collaborative (N3C).png

National Center for Advancing Translational Sciences

N3Community Forum

CTSA CCOS

Home

About

CTSA Groups and Meetings

Resources

News

Help

CTSA News

Date

Share this News Post

Rockefeller University CCTS R3 - Enhancing Scientific Rigor, Reproducibility, and Reporting Series